Searched for
SPECIALTY MEDICINES
Sun Pharma’s specialty portfolio, Organon deal to drive growth- Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%
- Time to be be cautious in the market, convinced about the business: 5 large-cap stocks with upside potential of up to 22%
- GDHS 2026 to focus on implementing AI actionScheduled for 20-21 November 2026, the Global Digital Health Summit will take place in New Delhi, highlighting the role of artificial intel...22 Oct, 2026, 03.51 PM IST
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up 32%, according to analystsHistory tells us that there is no way you can time the markets or predict its movement. But one thing can certainly be said: If the macro m...20 Oct, 2026, 06.03 AM IST
- The burden of cancer drugs: Millions battle exorbitant prices as life-saving treatment slips out of reachFor millions of cancer patients, the cost of treatment can be as frightening as the diagnosis. From steep markups to patented drugs that re...18 Oct, 2026, 09.18 AM IST
- 5 stocks with consistent score improvement and upside potential of up to 29 % in 1 year, according to analystsLook at how the market treated the stock of a large FMCG stock – one the best wealth creators of the past – just because it mentioned the r...17 Oct, 2026, 06.12 AM IST
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsThe next few weeks are critical, and one should not be in a hurry to make market-related decisions. Better to be cautious – to wait and wat...16 Oct, 2026, 10.12 AM IST
- Long-term investing is about looking beyond narratives, including AI: 5 large-caps with an upside potential of up to 24%As we see a recovery in the market, it is good to be cognizant of the fact that more than the narratives on the street, it is the earnings ...15 Oct, 2026, 04.19 PM IST
- 5 stocks with consistent score improvement and upside potential of up to 34% in 1 year, according to analystsGiven the current global and domestic situation, the chances are that the volatility quotient in the market will remain high. So, the best ...12 Oct, 2026, 03.24 PM IST
- CPHI Milan: Beyond generics, how Indian pharma is rewriting its global playbookAt CPHI Milan, Indian pharma players are looking beyond traditional exports, using partnerships, licensing, CDMO, and differentiated produc...08 Oct, 2026, 04.29 PM IST
- When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...07 Oct, 2026, 05.28 PM IST
- Meet world’s richest woman: Alice Walton got $33 billion richer without running Walmart, is building a $250 million tuition-free medical schoolAlice Walton, the world’s richest woman and Walmart heiress, saw her fortune rise by $33 billion in one year even though she does not run t...01 Oct, 2026, 10.32 PM IST
- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsWhat is needed in the markets these days is realism. Not fear or gloom, but a clear-eyed acceptance of where things actually stand. Realism...30 Sep, 2026, 10.40 PM IST
- 5 stocks with consistent score improvement and upside potential of up to 26% in 1 year, according to analystsWhen fear and uncertainty are the primary feelings on the street, the ability to rationally deal with negative news drops sharply. That is ...29 Sep, 2026, 10.21 AM IST
- Sun Pharma, Aurobindo Pharma, other stocks in focus as Trump exempts India from 100% tariffs on some speciality drugsIndian pharma stocks, including Sun Pharma and Aurobindo Pharma, are in focus after the US exempted India and 19 other countries from 100% ...29 Sep, 2026, 08.56 AM IST
- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsThere are times when a watchlist is more important than a buy list. But if you still insist on putting money in the market, look at fundame...24 Sep, 2026, 12.17 AM IST
- Zydus Lifesciences expects decent growth for five years as innovation matures: Sharvil PatelZydus Lifesciences is transitioning from a traditional pharmaceutical company to a more patient-driven organization. The company plans to f...24 Sep, 2026, 12.17 AM IST
- Zydus gearing up for next phase of growth, eyeing new areas: Sharvil Patel, MD"From 2030 and beyond, we will see strong earnings from pure discovery-led business, which is our central business, our oncology business a...23 Sep, 2026, 10.37 PM IST
- Short-term headwind? Yes. But the structure stays intact: 5 large-cap stocks with upside potential of up to 19%Wise men on the street will tell you it is foolish to try and time the market. And attempting to do so in the midst of a raging war is prob...15 Sep, 2026, 11.21 AM IST
Load More
